303 followers
RT @FrontPharmacol: New Research: Cost-effectiveness of adding empagliflozin to the standard of care for patients with heart failure with r…
RT @FrontPharmacol: New Research: Cost-effectiveness of adding empagliflozin to the standard of care for patients with heart failure with r…
New Research: Cost-effectiveness of adding empagliflozin to the standard of care for patients with heart failure with reduced ejection fraction from the perspective of healthcare system in Malaysia #pharmacology https://t.co/I52GtuznX6